← Eichor
Study identifier: NCT05179889 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Adjuvant mFOLFIRINOX for High-risk Stage III Colon Cancer

Condition: Colon Cancer Stage III  ·  Sponsor: Chungnam National University Hospital

PhasePhase 2/Phase 3
Planned participants308
Who can joinAll sexes, 20 Years to 75 Years
Healthy volunteersNo

About this study

A multicenter, open labeled randomized, phase II trial comparing mFOLFIRINOX and mFOLFOX6 as adjuvant treatment for high risk stage III (pT4N1/2 or pTanyN2) colon cancer

This description comes directly from the study's public registry record.

Talk to the study team

Kyung Ha Lee  ·  821042141415  ·  lllllkh@cnuh.co.kr

Always discuss trial participation with your own doctor first.

Locations (1)

Chungnam National University HospitalDaejeon, South KoreaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05179889